Understanding the pharmacokinetics of anxiolytic drugs

AC Altamura, D Moliterno, S Paletta… - Expert opinion on …, 2013 - Taylor & Francis
Introduction: Anxiety disorders are considered the most common mental disorders and they
can increase the risk for comorbid mood and substance use disorders, significantly …
被引用次数：138 相关文章

[引用][C] Understanding the pharmacokinetics of anxiolytic drugs

AC Altamura, D Moliterno, S Paletta, M Maffini… - Expert Opinion on Drug …, 2013 - cir.nii.ac.jp
Understanding the pharmacokinetics of anxiolytic drugs | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …

Understanding the pharmacokinetics of anxiolytic drugs.

AC Altamura, D Moliterno, S Paletta… - Expert Opinion on …, 2013 - europepmc.org
Anxiety disorders are considered the most common mental disorders and they can increase
the risk for comorbid mood and substance use disorders, significantly contributing to the …

Understanding the pharmacokinetics of anxiolytic drugs

AC Altamura, D Moliterno, S Paletta… - Expert opinion on …, 2013 - pubmed.ncbi.nlm.nih.gov
Introduction Anxiety disorders are considered the most common mental disorders and they
can increase the risk for comorbid mood and substance use disorders, significantly …

Understanding the pharmacokinetics of anxiolytic drugs

A Altamura, D Moliterno, S Paletta, M Maffini… - EXPERT OPINION ON …, 2013 - air.unimi.it
Introduction: Anxiety disorders are considered the most common mental disorders and they
can increase the risk for comorbid mood and substance use disorders, significantly …